Market
launch of Diclox forte
Market launch of Diclox forte
We are successfully establishing the Diclox forte pain relief gel from ratiopharm at pharmacy points of sale.
THE INITIAL SITUATION:
ratiopharm is Germany’s most widely-known pharmaceutical brand and leading generic drugmaker. A new pain gel was launched in January 2021. Diclox forte. It is bioequivalent to the original but less expensive.
THE PROJECT OBJECTIVES:
The original pain gel dominates the market. Pharmacy customers trust it, they have little inclination to change. Our challenge was to establish Diclox forte as a pain gel of equal status in pharmacies and to convince customers of its quality.
THE OUTCOME:
Pharmacy customers value the recommendations of PTAs and pharmacists, so we provided sales reps with promotional material. The aim was to bring on board pharmacy staff and to provide material to sell the product successfully. At PoS we ensured visibility of Diclox forte along the customer journey with aisle posters, window dressing, floor stickers, counter displays and behind-the-counter elements. Pharmacy staff were supported with training sessions and material for advising customers. Info brochures and giveaways were provided for pharmacy customers.
Pflichttext
Diclox forte
Wirkstoff: Diclofenac-N-Ethylethanamin. Anwendungsgebiete: für Erwachsene und Jugendliche ab 14 Jahren: Zur lokalen, symptomatischen Behandlung von Schmerzen bei akuten Zerrungen, Verstauchungen oder Prellungen infolge eines stumpfen Traumas. Warnhinweis: AM enth. Butylhydroxytoluol, Propylenglykol u. einen Duftstoff mit Benzylalkohol (0,15 mg/g Gel), Citronellol, Geraniol, Linalool, D-Limonen, Citral, Farnesol, Cumarin u. Eugenol. Apothekenpflichtig. Zu Risiken und Nebenwirkungen lesen Sie die Packungsbeilage und fragen Sie Ihre Ärztin, Ihren Arzt oder in Ihrer Apotheke. 07/25.